Table 1:
Baseline characteristics of the trial participants, by group
| Group; no. (%) or mean ± SD | |||
|---|---|---|---|
| Family heart-health intervention n = 211 | Control n = 215 | Total n = 426 | |
| Characteristic | |||
| Age, yr, mean ± SD | 52.0 ± 11.9 | 51.1 ± 11.3 | 51.5 ± 11.6 |
| Women | 128 (60.7) | 133 (61.9) | 261 (61.3) |
| White | 201 (95.3) | 205 (95.3) | 406 (95.3) |
| Married or living with partner | 164 (77.7) | 172 (80.0) | 336 (78.9) |
| Education, yr, mean ± SD | 14.6 ± 2.6 | 14.7 ± 2.6 | 14.7 ± 2.6 |
| Family history of premature CAD | 96 (45.5) | 95 (44.1) | 191 (44.8) |
| Current daily smoker | 20 (9.5) | 19 (8.8) | 39 (9.1) |
| No family doctor | 9 (4.2) | 14 (6.5) | 23 (5.4) |
| Body mass index ≥ 30 | 79 (37.4) | 87 (40.5) | 166 (39.0) |
| Waist circumference > 94 cm (men) or > 80 cm (women) | 64 (30.3) | 54 (25.1) | 118 (27.7) |
| Lipid-lowering therapy | 42 (19.9) | 51 (23.7) | 93 (21.8) |
| Antihypertensive therapy | 67 (31.8) | 52 (24.2) | 119 (27.9) |
| Smoking cessation pharmacotherapy* | 1 (5.0) | 2 (10.5) | 3 (7.7) |
| Relation to index patient | |||
| Spouse | 67 (31.8) | 65 (30.2) | 132 (31.0) |
| Offspring | 98 (46.4) | 101 (47.0) | 199 (46.7) |
| Sibling | 46 (21.8) | 49 (22.8) | 95 (22.3) |
| Percent risk of CAD event† over next 10 yr | 5.9 (6.6) | 5.8 (7.6) | 5.9 (7.1) |
Note: CAD = coronary artery disease, SD = standard deviation.
*
Based on participants who reported current daily smoking.
†
CHD event = nonfatal myocardial infarction or coronary death.